Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-05-21 @ 3:55 AM
Study NCT ID:
NCT00894894
Status:
COMPLETED
Last Update Posted:
2024-08-02
First Post:
2009-05-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies
Sponsor:
Astex Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumors | View |